HomeInsightsStock Comparison

Abbott India Ltd vs Glenmark Pharmaceuticals Ltd Stock Comparison

Abbott India Ltd vs Glenmark Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 18, 2025

Key Highlights

  • The Latest Trading Price of Abbott India Ltd is ₹ 34045 as of 18 Jul 10:06.
  • The P/E Ratio of Abbott India Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Abbott India Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 5814 crore on March 2020 to ₹ 27019 crore on March 2024 . This represents a CAGR of 35.97% over 5 years.
  • The revenue of Abbott India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Glenmark Pharmaceuticals Ltd for the Mar '25 is ₹ 3267 crore as compare to the Dec '24 revenue of ₹ 3418 crore. This represent the decline of -4.41%.
  • The ebitda of Abbott India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Glenmark Pharmaceuticals Ltd for the Mar '25 is ₹ 199.89 crore as compare to the Dec '24 ebitda of ₹ 631.36 crore. This represent the decline of -68.34%.
  • The net profit of Abbott India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 173.13 crore to ₹ 4.38 crore over 8 quarters. This represents a CAGR of -84.09% .
  • The Dividend Payout of Abbott India Ltd changed from 89.6 % on March 2020 to 72.53 % on March 2024 . This represents a CAGR of -4.14% over 5 yearsThe Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 5.21 % on March 2020 to 1.37 % on March 2024 . This represents a CAGR of -23.44% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Abbott India Ltd

  • Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
  • The Company sells its products through independent distributors primarily within India.
  • It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc.
  • Its global products include Brufen, Prothiaden, Thyronorm and Leptos. The company has four divisions.
  • The Primary Care division markets products in the areas of pain management and gastroenterology.

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
  • The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.

Abbott India Ltd News Hub

News

Abbott India Ltd down for fifth straight session

Abbott India Ltd is down for a fifth straight session today. The stock is quoting at Rs 34...

Read more

09 Jul 2025 13:35

News

Abbott India Ltd soars 3.58%, up for third straight session

Abbott India Ltd rose for a third straight session today. The stock is quoting at Rs 32815...

Read more

26 Jun 2025 13:05

News

Abbott India Ltd gains for fifth session

Abbott India Ltd gained for a fifth straight session today. The stock is quoting at Rs 311...

Read more

04 Jun 2025 13:00

News

Abbott India Ltd up for five straight sessions

Abbott India Ltd rose for a fifth straight session today. The stock is quoting at Rs 31190...

Read more

21 May 2025 13:00

News

Abbott India AGM scheduled

Abbott India announced that the 81th Annual General Meeting(AGM) of the company will be he...

Read more

16 May 2025 09:25

News

Board of Abbott India recommends final dividend

Abbott India announced that the Board of Directors of the Company at its meeting held on 1...

Read more

16 May 2025 09:25

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Ltd up for five straight sessions

Glenmark Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting...

Read more

16 Jul 2025 13:00

News

Glenmark Pharma receives warning letter from USFDA for Indore facility

The USFDA inspection was conducted between 3 February and 14 February 2025. In an official...

Read more

14 Jul 2025 10:08

News

Glenmark Pharmaceuticals Ltd up for third consecutive session

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

14 Jul 2025 13:05

News

Glenmark Pharma soars on AbbVie licensing deal for cancer therapy ISB 2001

The announcement follows a major licensing agreement with U.S. biopharma giant AbbVie. Und...

Read more

11 Jul 2025 11:54

News

Glenmark Pharmaceuticals Ltd leads gainers in 'A' group

Netweb Technologies India Ltd, Globus Spirits Ltd, VST Industries Ltd and Jaiprakash Power...

Read more

11 Jul 2025 12:00

News

IGI Therapeutics SA and AbbVie enter into an exclusive licensing agreement for ISB 2001

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovatio...

Read more

10 Jul 2025 19:51

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

SWOT Analysis Of Abbott India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Abbott India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Abbott India Ltd and Glenmark Pharmaceuticals Ltd

Which company has a larger market capitalization, Abbott India Ltd or Glenmark Pharmaceuticals Ltd?

Market cap of Abbott India Ltd is 72,522 Cr while Market cap of Glenmark Pharmaceuticals Ltd is 62,836 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Glenmark Pharmaceuticals Ltd?

The stock performance of Abbott India Ltd and Glenmark Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Glenmark Pharmaceuticals Ltd?

As of July 18, 2025, the Abbott India Ltd stock price is INR ₹34128.35. On the other hand, Glenmark Pharmaceuticals Ltd stock price is INR ₹2226.65.

How do dividend payouts of Abbott India Ltd and Glenmark Pharmaceuticals Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Glenmark Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions